BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/24/2022 2:13:21 PM | Browse: 809 | Download: 2671
Publication Name World Journal of Hepatology
Manuscript ID 72020
Country United States
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Observational Study
Article Title Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy
Manuscript Source Unsolicited Manuscript
All Author List Bahaaeldeen Ismail, Karim M Benrajab, Pablo Bejarano, Phillip Ruiz, Debbie Sears, Andreas Tzakis and Xaralambos Bobby Zervos
ORCID
Author(s) ORCID Number
Bahaaeldeen Ismail http://orcid.org/0000-0001-9583-8508
Karim M Benrajab http://orcid.org/0000-0002-7988-1159
Pablo Bejarano http://orcid.org/0000-0001-7933-9223
Phillip Ruiz http://orcid.org/0000-0003-2291-4594
Debbie Sears http://orcid.org/0000-0002-8376-9979
Andreas Tzakis http://orcid.org/0000-0001-8077-2315
Xaralambos Bobby Zervos http://orcid.org/0000-0001-6783-0525
Funding Agency and Grant Number
Corresponding Author Karim M Benrajab, MD, Assistant Professor, Internal Medicine/ Division of Digestive Diseases and Nutrition, University of Kentucky College of Medicine, 770 Rose Street, MN649, Lexington, KY 40536, United States. karimbenrajab@gmail.com
Key Words Immunosuppression; Liver transplantation; Recurrent hepatitis C; Sustained virologic response; Interferon
Core Tip Unexplained residual inflammation can be seen in a subset of liver transplant recipients successfully treated with direct-acting antiviral therapies; however, it does not seem to affect graft function. An extensive clinical and histopathologic workup should still be performed to exclude other potentially treatable conditions.
Publish Date 2022-03-24 14:13
Citation Ismail B, Benrajab KM, Bejarano P, Ruiz P, Sears D, Tzakis A, Zervos XB. Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy. World J Hepatol 2022; 14(3): 602-611
URL https://www.wjgnet.com/1948-5182/full/v14/i3/602.htm
DOI https://dx.doi.org/10.4254/wjh.v14.i3.602
Full Article (PDF) WJH-14-602.pdf
Full Article (Word) WJH-14-602.docx